• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

软骨发育不全患者身体比例的发育:坐高、腿长、臂展和足长。

Development of body proportions in achondroplasia: Sitting height, leg length, arm span, and foot length.

作者信息

Merker Andrea, Neumeyer Luitgard, Hertel Niels Thomas, Grigelioniene Giedre, Mohnike Klaus, Hagenäs Lars

机构信息

Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.

Pediatric Endocrinology Unit, Karolinska University Hospital, Stockholm, Sweden.

出版信息

Am J Med Genet A. 2018 Sep;176(9):1819-1829. doi: 10.1002/ajmg.a.40356. Epub 2018 Aug 27.

DOI:10.1002/ajmg.a.40356
PMID:30152086
Abstract

The aims of this study was to construct references for sitting height, leg length, arm span, relative sitting height (sitting height/height), and foot length and to discuss the development for these anthropometric variables in achondroplasia. Sex-specific references covering ±2 SD are presented for ages 2-20 years. Legs and arms in achondroplasia are already at 2 years of age considerably shorter than in the general population and this deviation increases with age. At adult ages, legs are almost 50% shorter than in the general population and arm span roughly 35% shorter. As sitting height is only mildly affected, relative sitting height position develops far beyond normal ranges. Foot length is also not as affected as limbs.

摘要

本研究的目的是构建坐高、腿长、臂展、相对坐高(坐高/身高)和足长的参考标准,并探讨软骨发育不全患者这些人体测量变量的发育情况。给出了2至20岁涵盖±2标准差的按性别划分的参考标准。软骨发育不全患者在2岁时腿部和手臂就已经比一般人群明显短,且这种偏差随年龄增加。在成年期,腿部比一般人群短近50%,臂展约短35%。由于坐高仅受到轻微影响,相对坐高位置的发育远超正常范围。足长也不像四肢那样受到严重影响。

相似文献

1
Development of body proportions in achondroplasia: Sitting height, leg length, arm span, and foot length.软骨发育不全患者身体比例的发育:坐高、腿长、臂展和足长。
Am J Med Genet A. 2018 Sep;176(9):1819-1829. doi: 10.1002/ajmg.a.40356. Epub 2018 Aug 27.
2
Leg length, sitting height, and body proportions references for achondroplasia: New tools for monitoring growth.软骨发育不全的腿长、坐高和身体比例参考标准:监测生长的新工具。
Am J Med Genet A. 2018 Apr;176(4):896-906. doi: 10.1002/ajmg.a.38633. Epub 2018 Feb 9.
3
Clinical charts for surveillance of growth and body proportion development in achondroplasia and examples of their use.临床图表用于监测软骨发育不全患者的生长和身体比例发育及其使用示例。
Am J Med Genet A. 2021 Feb;185(2):401-412. doi: 10.1002/ajmg.a.61974. Epub 2020 Nov 21.
4
Pubertal growth in height, sitting height and leg length in achondroplasia.成骨不全症患者的青春期身高、坐高和下肢长增长。
Ann Hum Biol. 2021 Feb;48(1):8-14. doi: 10.1080/03014460.2021.1883109. Epub 2021 Mar 23.
5
[Body proportions of Danish children. Curves for sitting height ratio, subischial length and arm span].[丹麦儿童的身体比例。坐高比、坐骨下长度和臂展曲线]
Ugeskr Laeger. 1995 Dec 4;157(49):6876-81.
6
Correlations among height, leg length and arm span in growing Korean children.韩国成长中儿童身高、腿长和臂展之间的相关性。
Ann Hum Biol. 1995 Sep-Oct;22(5):443-58. doi: 10.1080/03014469500004112.
7
A longitudinal study of growth patterns in schoolchildren in one Taipei District. II: Sitting height, arm span, body mass index and skinfold thickness.台北某区学童生长模式的纵向研究。II:坐高、臂展、体重指数和皮褶厚度。
J Chin Med Assoc. 2005 Jan;68(1):16-20. doi: 10.1016/S1726-4901(09)70126-1.
8
Evaluation of arm span and sitting height as proxy for height in children with sickle cell anemia in Lagos, Nigeria.尼日利亚拉各斯镰状细胞贫血患儿中臂展和坐高作为身高替代指标的评估。
J Am Coll Nutr. 2014;33(6):437-41. doi: 10.1080/07315724.2013.875356. Epub 2014 Jun 25.
9
Body segment lengths and arm span in healthy men and women and patients with vertebral fractures.健康男性和女性以及椎体骨折患者的身体各节段长度和臂展。
Osteoporos Int. 2004 Jan;15(1):43-8. doi: 10.1007/s00198-003-1496-y. Epub 2003 Sep 23.
10
Reference charts of sitting height, leg length and body proportions for Chinese children aged 0-18 years.0至18岁中国儿童坐高、腿长及身体比例参考图表。
Ann Hum Biol. 2015;42(3):223-30. doi: 10.3109/03014460.2014.934283. Epub 2014 Nov 25.

引用本文的文献

1
An AI-assisted tool for automated growth monitoring in pediatric achondroplasia.一种用于小儿软骨发育不全自动生长监测的人工智能辅助工具。
Eur J Pediatr. 2025 Jul 18;184(8):490. doi: 10.1007/s00431-025-06321-3.
2
Differences in gait parameters between children with achondroplasia and an age-matched control group of typically developed children in the age range of 6 to 12 years.6至12岁软骨发育不全儿童与年龄匹配的正常发育儿童对照组之间的步态参数差异。
PLoS One. 2025 Jun 18;20(6):e0326184. doi: 10.1371/journal.pone.0326184. eCollection 2025.
3
Real-World Safety and Effectiveness of Vosoritide in Achondroplasia: Results from a Single Center in Portugal.
伏索利肽治疗软骨发育不全的真实世界安全性和有效性:葡萄牙单中心研究结果
Adv Ther. 2025 Jun 5. doi: 10.1007/s12325-025-03223-6.
4
Real-world Outcome of Vosoritide Treatment in Children With Achondroplasia: A 12-month Retrospective Observational Study.维索利肽治疗软骨发育不全儿童的真实世界结局:一项为期12个月的回顾性观察研究。
J Endocr Soc. 2025 Mar 8;9(5):bvaf041. doi: 10.1210/jendso/bvaf041. eCollection 2025 Mar 24.
5
Considerations for Anthropometry Specific to People with Disproportionate Short Stature.针对身材不成比例矮小者的人体测量学考量
Adv Ther. 2025 Mar;42(3):1291-1311. doi: 10.1007/s12325-024-03061-y. Epub 2025 Feb 5.
6
[Achondroplasia : New era of orthopedic treatment?].[软骨发育不全:骨科治疗的新时代?]
Orthopadie (Heidelb). 2024 Dec;53(12):974-984. doi: 10.1007/s00132-024-04581-9. Epub 2024 Nov 20.
7
International expert opinion on the considerations for combining vosoritide and limb surgery: a modified delphi study.国际专家关于 vosoritide 与肢体手术联合应用的考虑因素的意见:一项改良德尔菲研究。
Orphanet J Rare Dis. 2024 Sep 17;19(1):347. doi: 10.1186/s13023-024-03236-4.
8
Natural disease course modeling of achondroplasia to evaluate the efficacy of recifercept in the absence of a placebo control arm in phase II study.成骨不全症自然病程建模,以评估二期研究中无安慰剂对照臂时 recifercept 的疗效。
CPT Pharmacometrics Syst Pharmacol. 2024 Jul;13(7):1103-1116. doi: 10.1002/psp4.13143. Epub 2024 Apr 29.
9
The Relationship Between Limb Lengthening Rate and Callus Quality in Patients with Achondroplasia.软骨发育不全患者肢体延长率与骨痂质量的关系
Indian J Orthop. 2022 Jul 16;56(11):1891-1896. doi: 10.1007/s43465-022-00694-5. eCollection 2022 Nov.
10
Phase 1 safety, tolerability, pharmacokinetics and pharmacodynamics results of a long-acting C-type natriuretic peptide prodrug, TransCon CNP.长效 C 型利钠肽前药 TransCon CNP 的 1 期安全性、耐受性、药代动力学和药效学研究结果。
Br J Clin Pharmacol. 2022 Nov;88(11):4763-4772. doi: 10.1111/bcp.15369. Epub 2022 Jun 1.